+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Short-read Sequencing Market Size, Share & Trends Analysis Report By Technology (Next Generation Sequencing, Sanger Sequencing), By Product, By Application, By End Use, By Workflow, And Segment Forecasts, 2019 - 2025

  • ID: 4871467
  • Report
  • October 2019
  • Region: Global
  • 150 Pages
  • Grand View Research

FEATURED COMPANIES

  • 10x Genomics
  • Agilent Technologies
  • BGI Genomics
  • F. Hoffmann-La Roche AG
  • Fasteris SA
  • GE Healthcare
The global short-read sequencing market size is expected to reach USD 18.64 billion by 2025, at a 11.32% CAGR during the forecast period, according to this report. Rising demand for personalized medicine and companion diagnostics is anticipated to drive the growth.

In addition, initiatives taken by key players to enhance their market presence are expected to boost revenue generation in the market for short-read sequencing. For instance, in March 2019, Illumina partnered with Boai NKY Medical Holdings, a China-based producer of polyvinylpyrrolidone, to develop NGS-based systems for in-vitro diagnosis of hereditary diseases. The novel systems would be developed by using NKY's library prep kits and analysis software and Illumina’s MiniSeq system.

Other major market players have also entered into partnerships and collaborations for expansion in the Asian market as Asia Pacific offers a wide customer-base of patients suffering from chronic disorders that can be diagnosed easily using sequencing methods.

Major application areas of short-read sequencing include reproductive screening, oncology, noninvasive prenatal testing, infectious disease, and pharmacogenomics. A rise in adoption of sequencing platforms for diagnosis of the aforementioned clinical conditions is expected to have a positive impact on the overall market growth.

Further key findings from the report suggest:
  • Next-generation Sequencing (NGS) accounted for the largest revenue share in 2018 and is expected to maintain its dominance over the forecast period, owing to the presence of substantial platforms and services offered by prominent participants in NGS is anticipated to add to the market revenue

  • Consumables product segment is expected to witness lucrative growth over the forecast period, since these products are short-lived and exhibit higher usability

  • Short read methods are most commonly adopted in the field of oncology owing to an increase in the adoption of NGS technology to advance personalized treatment for different types of cancer

  • Sequencing step dominated with the largest market share in 2018 as it is the important step of the protocols implemented in terms of time as well as consumables

  • Academic research held the largest market share in 2018 as a consequence of higher usage of these protocols in research, academic workshops, and on-site bioinformatics courses offered by universities

  • Illumina, Inc.; Thermo Fisher Scientific Inc.; 10x Genomics; and Qiagen N.V. are the prominent participants operating in the short-read sequencing market. These participants engage in new product development and strategic alliances to maintain the market share


This product will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 10x Genomics
  • Agilent Technologies
  • BGI Genomics
  • F. Hoffmann-La Roche AG
  • Fasteris SA
  • GE Healthcare

Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 Internal database
2.1.3 Secondary sources:
2.1.4 Primary research:
2.1.5 Details of primary research
2.2 Information or Data Analysis
2.2.1 Data analysis models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity flow analysis (Model 1)
2.4.1.1 Approach 1: Commodity flow approach
2.5 List of Secondary Sources
2.6 List of Primary Sources
2.7 Objectives
2.7.1 Objective 1
2.7.2 Objective 2
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Higher adoption of short-read sequencing over long read sequencing
3.1.1.2 Decrease in cost for genetic sequencing
3.1.1.3 Rise in adoption of personalized medicine and companion diagnostics
3.1.1.4 Rise in collaborations & partnerships for genetic sequencing
3.1.2 Market restraint analysis
3.1.2.1 Limitation of short read sequences to resolve complex genomic regions
3.1.2.2 Ethical and legal limitations
3.2 Penetration & Growth Prospect Mapping for Applications, 2018
3.3 Short Read Sequencing - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Short Read Sequencing Market: Technology Estimates & Trend Analysis
4.1 Short Read Sequencing Market: Technology Movement Analysis, 2018 & 2025
4.2 Next-Generation Sequencing
4.2.1 Short read next-generation sequencing market, 2014 - 2025 (USD Million)
4.2.2 Sanger sequencing
4.2.2.1 Short read sanger sequencing market, 2014 - 2025 (USD Million)
Chapter 5 Short Read Sequencing Market: Product Estimates & Trend Analysis
5.1 Short Read Sequencing Market: Product Movement Analysis, 2018 & 2025
5.2 Instruments
5.2.1 Short read sequencing instruments market, 2014 - 2025 (USD Million)
5.3 Consumables
5.3.1 Short read sequencing market for consumables, 2014 - 2025 (USD Million)
5.4 Services
5.4.1 Short read sequencing services market, 2014 - 2025 (USD Million)
Chapter 6 Short Read Sequencing Market: Application Estimates & Trend Analysis
6.1 Short Read Sequencing Market: Application Movement Analysis, 2018 & 2025
6.2 Oncology
6.2.1 Short read sequencing market for oncology, 2014 - 2025 (USD Million)
6.3 Clinical Investigation
6.3.1 Short read sequencing market for clinical investigation, 2014 - 2025 (USD Million)
6.4 Reproductive Health
6.4.1 Short read sequencing market for reproductive health, 2014 - 2025 (USD Million)
6.5 HLA Typing
6.5.1 Short read sequencing market for HLA typing, 2014 - 2025 (USD Million)
6.6 Metagenomics, Epidemiology & Drug Development
6.6.1 Short read sequencing market for metagenomics, epidemiology & drug development, 2014 - 2025 (USD Million)
6.7 Agrigenomics & Forensics
6.7.1 Short read sequencing market for agrigenomics & forensics, 2014 - 2025 (USD Million)
6.8 Consumer Genomics
6.8.1 Short read sequencing market for consumer genomics, 2014 - 2025 (USD Million)
Chapter 7 Short Read Sequencing Market: Workflow Estimates & Trend Analysis
7.1 Read Sequencing Market: Workflow Movement Analysis
7.2 Pre-sequencing
7.2.1 Short read sequencing market for pre-sequencing, 2014 - 2025 (USD Million)
7.3 Sequencing
7.3.1 Short read sequencing market for sequencing, 2014 - 2025 (USD Million)
7.4 Data Analysis
7.4.1 Short read sequencing market for data analysis, 2014 - 2025 (USD Million)
Chapter 8 Short Read Sequencing Market: End Use Estimates & Trend Analysis
8.1 Short Read Sequencing Market: End Use Movement Analysis, 2018 & 2025
8.2 Academic Research
8.2.1 Short read sequencing market for academic research, 2014 - 2025 (USD Million)
8.3 Clinical Research
8.3.1 Short read sequencing market for clinical research, 2014 - 2025 (USD Million)
8.4 Hospitals & Clinics
8.4.1 Short read sequencing market for hospitals & clinics, 2014 - 2025 (USD Million)
8.5 Pharma & Biotech Entities
8.5.1 Short read sequencing market for pharma & biotech entities, 2014 - 2025 (USD Million)
8.6 Other End Users
8.6.1 Short read sequencing market for other end users, 2014 - 2025 (USD Million)
Chapter 9 Short Read Sequencing Market:: Regional Estimates & Trend Analysis, by Technology, Product, Application, Workflow, and End Use
9.1 Short Read Sequencing Market Share By Region, 2018 & 2025
9.2 North America
9.2.1 North America short-read sequencing market, 2014 - 2025 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. short-read sequencing market, 2014 - 2025 (USD Million)
9.2.3 Canada
9.2.3.1 Canada short-read sequencing market, 2014 - 2025 (USD Million)
9.3 Europe
9.3.1 Europe short-read sequencing market, 2014 - 2025 (USD Million)
9.3.2 Germany
9.3.2.1 Germany short-read sequencing market, 2014 - 2025 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. short-read sequencing market, 2014 - 2025 (USD Million)
9.4 Asia Pacific
9.4.1 Asia-Pacific short-read sequencing market, 2014 - 2025 (USD Million)
9.4.2 Japan
9.4.2.1 Japan short-read sequencing market, 2014 - 2025 (USD Million)
9.4.3 China
9.4.3.1 China short-read sequencing market, 2014 - 2025 (USD Million)
9.5 Latin America
9.5.1.1 Latin America short-read sequencing market, 2014 - 2025 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil short-read sequencing market, 2014 - 2025 (USD Million)
9.6 Middle East & Africa (MEA)
9.6.1.1 MEA short-read sequencing market, 2014 - 2025 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa short-read sequencing market, 2014 - 2025 (USD Million)
Chapter 10 Competitive Landscape
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Company Profiles
10.4 Thermo Fisher Scientific Inc.
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 F. Hoffmann-La Roche AG
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Illumina, Inc.
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 Genewiz
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Genscript Biotech Corporation
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 10x Genomics
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 Macrogen, Inc.
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.10.4 Strategic initiatives
10.11 Qiagen N.V.
10.11.1 Company overview
10.11.2 Financial performance
10.11.3 Product benchmarking
10.11.4 Strategic initiatives
10.12 Agilent Technologies
10.12.1 Company overview
10.12.2 Financial performance
10.12.3 Product benchmarking
10.12.4 Strategic initiatives
10.13 BGI Genomics
10.13.1 Company overview
10.13.2 Financial performance
10.13.3 Product benchmarking
10.13.4 Strategic initiatives
10.14 Fasteris SA
10.14.1 Company overview
10.14.2 Financial performance
10.14.3 Product benchmarking
10.14.4 Strategic initiatives
10.15 GE Healthcare
10.15.1 Company overview
10.15.2 Financial performance
10.15.3 Product benchmarking
10.15.4 Strategic initiatives
Note: Product cover images may vary from those shown
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Genewiz
  • Genscript Biotech Corporation
  • 10x Genomics
  • Macrogen, Inc.
  • Qiagen N.V.
  • Agilent Technologies
  • BGI Genomics
  • Fasteris SA
  • GE Healthcare
Note: Product cover images may vary from those shown

Loading
LOADING...